GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avivagen Inc (TSXV:VIV) » Definitions » 3-Year EPS without NRI Growth Rate

Avivagen (TSXV:VIV) 3-Year EPS without NRI Growth Rate : 34.70% (As of Jul. 2023)


View and export this data going back to 2003. Start your Free Trial

What is Avivagen 3-Year EPS without NRI Growth Rate?

Avivagen's EPS without NRI for the three months ended in Jul. 2023 was C$-0.01.

During the past 3 years, the average EPS without NRI Growth Rate was 34.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was 24.60% per year. During the past 10 years, the average EPS without NRI Growth Rate was 10.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Avivagen was 40.30% per year. The lowest was -16.90% per year. And the median was 11.80% per year.


Competitive Comparison of Avivagen's 3-Year EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Avivagen's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avivagen's 3-Year EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Avivagen's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Avivagen's 3-Year EPS without NRI Growth Rate falls into.



Avivagen 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Avivagen  (TSXV:VIV) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Avivagen 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Avivagen's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Avivagen (TSXV:VIV) Business Description

Industry
Traded in Other Exchanges
Address
100 Sussex Drive, Ottawa, ON, CAN, K1A 0R6
Avivagen Inc is a Canadian-based company operating in the healthcare sector. It develops science-based, natural health products for animals. It develops and commercializes products for livestock feeds to replace antibiotics for growth promotion and to help prevent disease by supporting the animal's health defenses. The company's products are based on OxC-beta Technology. Its geographical segments include the Philippines, which is the key revenue driver; Mexico; Thailand; United States; Malaysia; Taiwan; Brazil; and others.
Executives
Jeffrey Jay Kraws Director

Avivagen (TSXV:VIV) Headlines

From GuruFocus

1Q22 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 06-19-2022

4Q21 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 02-23-2022

1Q21 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 05-12-2021

2Q22 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 07-26-2022

A Trio of High Earnings Return Stocks

By Alberto Abaterusso Alberto Abaterusso 02-04-2021

1Q22 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 05-10-2022

1Q23 Results: Telef�nica Brasil S.A.

By PRNewswire PRNewswire 05-09-2023

DORCHESTER WEALTH MANAGEMENT Co Buys 2, Sells 3 in 2nd Quarter

By GuruFocus Research GuruFocus Editor 08-04-2022